Seminars in Diagnostic Pathology
Volume 25, Issue 3 , Pages 147-153, August 2008

The benign versus malignant paradigm in oncologic pathology: a critique

  • Juan Rosai, MD

      Affiliations

    • Centro Diagnostico Italiano, Milan, Italy
    • Genzyme Corporation, New York, New York
    • Corresponding Author InformationAddress for correspondence: Juan Rosai, MD, Centro Consulenze Anatomia Patologica Oncologica, Centro Diagnostico Italiano (CDI), Via Saint Bon,20, 20147 Milano, Italy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0740-2570(08)00056-7

doi:10.1053/j.semdp.2008.07.002

Seminars in Diagnostic Pathology
Volume 25, Issue 3 , Pages 147-153, August 2008

Article Tools

* Image Usage & Resolution